Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation
Published 2022 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Efficacy of Fecal Microbiota Transplantation for Patients With Irritable Bowel Syndrome at 3 Years After Transplantation
Authors
Keywords
-
Journal
GASTROENTEROLOGY
Volume -, Issue -, Pages -
Publisher
Elsevier BV
Online
2022-06-14
DOI
10.1053/j.gastro.2022.06.020
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Responses to faecal microbiota transplantation in female and male patients with irritable bowel syndrome
- (2021) Magdy El-Salhy et al. WORLD JOURNAL OF GASTROENTEROLOGY
- Long‐term effects of fecal microbiota transplantation (FMT) in patients with irritable bowel syndrome
- (2021) Magdy El‐Salhy et al. NEUROGASTROENTEROLOGY AND MOTILITY
- Faecal microbial transplantation in IBS: ready for prime time?
- (2020) Giovanni Barbara et al. GUT
- Long-Term Efficacy and Safety of Fecal Microbiota Transplantation for Treatment of Recurrent Clostridioides difficile Infection
- (2020) Bryce K. Perler et al. JOURNAL OF CLINICAL GASTROENTEROLOGY
- Fecal Microbiota Transplantation Reduces Symptoms in Some Patients With Irritable Bowel Syndrome with Predominant Abdominal Bloating: Short- and Long-Term Results from a Placebo-Controlled Randomized Trial
- (2020) Tom Holvoet et al. GASTROENTEROLOGY
- FMT in IBS: how cautious should we be?
- (2020) Magdy El-Salhy GUT
- The Genus Alistipes: Gut Bacteria With Emerging Implications to Inflammation, Cancer, and Mental Health
- (2020) Bianca J. Parker et al. Frontiers in Immunology
- Gut Microbiota in Patients With Irritable Bowel Syndrome—A Systematic Review
- (2019) Rapat Pittayanon et al. GASTROENTEROLOGY
- Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
- (2019) Zachariah DeFilipp et al. NEW ENGLAND JOURNAL OF MEDICINE
- Fecal Microbiota Transplantation for Dysbiosis — Predictable Risks
- (2019) Martin J. Blaser NEW ENGLAND JOURNAL OF MEDICINE
- Diet in Irritable Bowel Syndrome (IBS): Interaction with Gut Microbiota and Gut Hormones
- (2019) Magdy El-Salhy et al. Nutrients
- Efficacy of faecal microbiota transplantation for patients with irritable bowel syndrome in a randomised, double-blind, placebo-controlled study
- (2019) Magdy El-Salhy et al. GUT
- Dysbiosis in Functional Bowel Disorders
- (2018) Paul Enck et al. ANNALS OF NUTRITION AND METABOLISM
- The Fatigue Assessment Scale
- (2018) Celine Hendriks et al. CURRENT OPINION IN PULMONARY MEDICINE
- Fecal microbiota transplantation for managing irritable bowel syndrome
- (2018) Magdy El-Salhy et al. Expert Review of Gastroenterology & Hepatology
- Effect of cryopreservation and lyophilization on viability and growth of strict anaerobic human gut microbes
- (2018) Lea Bircher et al. Microbial Biotechnology
- Eubacterium maltosivorans sp. nov., a novel human intestinal acetogenic and butyrogenic bacterium with a versatile metabolism
- (2018) Yuan Feng et al. INTERNATIONAL JOURNAL OF SYSTEMATIC AND EVOLUTIONARY MICROBIOLOGY
- Gut microbiota composition and functional changes in inflammatory bowel disease and irritable bowel syndrome
- (2018) Arnau Vich Vila et al. Science Translational Medicine
- Erratum: Strains, functions and dynamics in the expanded Human Microbiome Project
- (2017) Jason Lloyd-Price et al. NATURE
- Deviations in human gut microbiota: a novel diagnostic test for determining dysbiosis in patients with IBS or IBD
- (2015) C. Casén et al. ALIMENTARY PHARMACOLOGY & THERAPEUTICS
- An irritable bowel syndrome subtype defined by species-specific alterations in faecal microbiota
- (2011) Ian B Jeffery et al. GUT
- Diversity, metabolism and microbial ecology of butyrate-producing bacteria from the human large intestine
- (2009) Petra Louis et al. FEMS MICROBIOLOGY LETTERS
- Evaluation of the Birmingham IBS symptom questionnaire
- (2008) Andrea K Roalfe et al. BMC GASTROENTEROLOGY
- Faecalibacterium prausnitzii is an anti-inflammatory commensal bacterium identified by gut microbiota analysis of Crohn disease patients
- (2008) H. Sokol et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchBecome a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get Started